Caribou Biosciences, Inc.CRBUNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-19.11%
↓ 327% below average
Average (22q)
8.42%
Historical baseline
Range
High:145.28%
Low:-32.94%
Volatility
2116.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -19.11% |
| Q2 2025 | -22.06% |
| Q1 2025 | 16.63% |
| Q4 2024 | 0.14% |
| Q3 2024 | -14.26% |
| Q2 2024 | 5.01% |
| Q1 2024 | 8.02% |
| Q4 2023 | 9.43% |
| Q3 2023 | 7.85% |
| Q2 2023 | 3.09% |
| Q1 2023 | -2.38% |
| Q4 2022 | 31.74% |
| Q3 2022 | -11.46% |
| Q2 2022 | 62.16% |
| Q1 2022 | -7.86% |
| Q4 2021 | -4.56% |
| Q3 2021 | 28.44% |
| Q2 2021 | 21.27% |
| Q1 2021 | -32.94% |
| Q4 2020 | 145.28% |
| Q3 2020 | -18.47% |
| Q2 2020 | -12.28% |
| Q1 2020 | 0.00% |